Panion Animal Health AB develops an innovative treatment for epilepsy in dogs and has just started the clinical phase.
Panion has been selected to present its business plan at the 2019 Animal Health Investment Forum as part of the Innovation Showcase of the year, in the programme on translational technology from human-to-veterinary pharma.
Panion’s chairman of the board, Lars Thunberg, will inform the audience about the promising business idea in veterinary medicines and the progress over the last two years. The focus will be on the commercial elements of Panion’s business plan and sets out the possible road to commercialisation.
The Animal Health Investment Europe is a premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners.